Clinical trial
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
NCT00022763 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00022763 |
|---|---|
| Title | T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents |
| Official title | A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Collaborators | Trimeris Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Enfuvirtide |
| Enrollment | 52 |
| Start date | Aug 1, 2001 |
| Primary completion | Dec 1, 2004 |
| First posted | Aug 31, 2001 |
| Last update posted | Feb 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: